|
Jul 1
|
CRO Activity and Intel Report, Q1 2025 Featuring ICON, Astrazeneca, Akesobio, CSPPC Pharmaceutical, ImmunityBio, and Boryung
|
|
Jun 30
|
AstraZeneca (AZN) Announces Strategic Research Collaboration with CSPC Pharmaceuticals
|
|
Jun 30
|
Rakovina Therapeutics Highlights Strong H1 Progress and Unveils Strategic Priorities for H2 2025
|
|
Jun 29
|
Evotec (EVO) Joins NURTuRE-AKI Consortium to Advance Kidney Injury Drug Discovery
|
|
Jun 28
|
AstraZeneca (AZN) Scores FDA Approval for Datroway, First TROP2 ADC for Lung Cancer
|
|
Jun 27
|
Onco-Innovations Welcomes AstraZeneca's Interest in Founding Role in PROmAI - an Inka-led AI-Oncology Consortium
|
|
Jun 27
|
3 UK Stocks That May Be Trading Below Their Estimated Value In June 2025
|
|
Jun 27
|
Why AstraZeneca risks Trump’s wrath with bet on China
|
|
Jun 26
|
Trump Vows To Cut 'The Best Deal' On Drug Prices. What To Expect.
|
|
Jun 26
|
Is Astrazeneca (AZN) a Buy as Wall Street Analysts Look Optimistic?
|
|
Jun 26
|
Ephicacy Appoints Névine Zariffa to Its Board of Directors
|
|
Jun 26
|
UK's June 2025 Stock Picks Estimated Below Intrinsic Value
|
|
Jun 25
|
IonQ (NYSE:IONQ) Achieves Quantum Leap In Simulating Fundamental Physics With New Quantum Technique
|
|
Jun 25
|
AstraZeneca (LSE:AZN) Gains FDA Approval For Datroway In Treating Advanced Lung Cancer
|
|
Jun 25
|
AstraZeneca and Daiichi Sankyo Treatment Wins First of Its Kind FDA Blessing to Treat Lung Cancer
|
|
Jun 25
|
AstraZeneca Presents Positive Phase I/II Data for Surovatamig in B-cell ALL at EHA 2025
|
|
Jun 25
|
Human Magic Acquires TapIn to Pioneer the Future of Work
|
|
Jun 24
|
Here's Why Astrazeneca (AZN) is a Strong Growth Stock
|
|
Jun 24
|
FDA Grants Label Expansion to AstraZeneca's Datroway in Lung Cancer
|
|
Jun 24
|
DATROWAY® approved in the US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer
|